20
Participants
Start Date
September 18, 2023
Primary Completion Date
December 31, 2025
Study Completion Date
June 30, 2026
LuxValve PLlus
The LuX-Valve (Jenscare Biotechnology) is a radial force-independent orthotopic TTVR device. The feasibility and efficacy of this device have been reported by several studies (11-13). However, this valve was implanted through right atrial access, where a small incision of the right chest and right atrium is needed. The LuX-Valve Plus valve replacement system is the second-generation version of the LuX-Valve and can be implanted through the jugular vein.
Prince of Wales Hospital, Hong Kong
Prince of Wales Hospital, Shatin, Hong Kong
OTHER